Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy

نویسندگانJafar Mohseni- ZAMH Zabidi-Hussin- Teguh Haryo Sasongko
نشریهGenetics and Molecular Biology
ارائه به نام دانشگاهUSM
شماره صفحات299-307
شماره سریال3
شماره مجلد36
ضریب تاثیر (IF)0.5
نوع مقالهFull Paper
تاریخ انتشار2013
رتبه نشریهISI (WOS)
نوع نشریهچاپی
کشور محل چاپایران

چکیده مقاله

Histone acetylation plays an important role in regulation of transcription in eukaryotic cells by promoting a more relaxed chromatin structure necessary for transcriptional activation. Histone deacetylases (HDACs) remove acetyl groups and suppress gene expression. HDAC inhibitors (HDACIs) are a group of small molecules that promote gene transcription by chromatin remodeling and have been extensively studied as potential drugs for treating of spinal muscular atrophy. Various drugs in this class have been studied with regard to their efficacy in increasing the expression of survival of motor neuron (SMN) protein. In this review, we discuss the current literature on this topic and summarize the findings of the main studies in this field.

لینک ثابت مقاله

متن کامل مقاله

tags: HDACi; molecular therapy; spinal muscular atrophy